Navigation Links
EvaluatePharma Japan KK - Now Open for Business in Tokyo
Date:9/15/2011

LONDON and TOKYO, September 15, 2011 /PRNewswire/ --

EvaluatePharma Ltd, the research company, is delighted to announce the official launch of EvaluatePharma Japan KK.  With a team based in Tokyo, EvaluatePharma Japan KK will be ideally placed to support our clients and prospects in Japan.

"Japan is a very important market for us.  We have managed to build close relationships with our major customers from a distance, but it is now time for us to show our commitment to the Japanese market with a dedicated local operation," said CEO Dr Jonathan de Pass.

With the establishment of EvaluatePharma Japan KK, we welcome Hiroshi Yamazaki, who has joined as a regional director. Mr. Yamazaki is responsible for development of EvaluatePharma's business in Japan.  With many years' experience servicing the pharmaceutical industry, he and the EvaluatePharma Japan team are well positioned to expand and support the business in this territory.

The launch was marked with a reception at the British Embassy in Tokyo, where Dr Jonathan de Pass, founder and CEO of EvaluatePharma Ltd, presented "Darwin's Medicine - Survival of the Fittest in the Pharma Industry."  Drawing on EvaluatePharma's World Preview 2016 (2011 edition), and "The Future of Pharma" by Professor Brian D. Smith, Dr de Pass discussed the evolutionary forces shaping the pharmaceuticals industry in the face of catastrophic loss of revenue post "patent cliff" and the alarming decline in R&D productivity.

Notes to editors

About EvaluatePharma ® - http://www.evaluatepharma.com

Set up in 1996 by former top pharma analyst Dr. Jonathan de Pass, EvaluatePharma® is the premier source for pharma and biotech analysis.

EvaluatePharma was the first company to supply reliable consensus forecasts of global drug sales and now provides standardised worldwide financial and forecast models with consensus product forecasts to 2016, data on R&D pipelines, licensing deals, patent risk and M&A deals, along with analytical tools that include Merge Company and Peer Group Analyzer and NPV (Net Present Value) analysis for more than 3000 products.

Launched in 2007, EvaluatePharma®Alpha offers an off-the-shelf valuation service to quantify the impact of market events on product, portfolio and company valuation - NPV Analyzer, Calendar of Events and the daily news service EP Vantage.


'/>"/>
SOURCE EvaluatePharma Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. EYLEA™ (aflibercept injection) Submitted in Japan for Marketing Authorization for the Treatment of Wet Age-Related Macular Degeneration
2. Reverse NanoJapan: Rice to host 25-30 Japanese students
3. Cellectis bioresearch Appoints Wako as Exclusive Distributor of its Genome Customization Solutions in Japan
4. Epichem and AR Brown Sign Exclusive Distribution Agreement for Japan, Taiwan, China and South Korea
5. Silence Therapeutics Issued Japanese Patent Covering its Core RNA Interference (RNAi) Technology
6. The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan
7. 50,000 Potassium Iodide Pills Donated to Japan
8. UBM Announces Content for 10th Annual Japanese Pharma & Bio Events
9. Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan; Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
10. Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
11. Reportlinker Adds The 2011 Immunoprotein Diagnostics Market: US, Europe, Japan Test Volume and Sales Forecasts by Country and Market Segment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... 29, 2016 According to ... Research "Separation Systems for Commercial Biotechnology Market - ... Forecast 2015 - 2023", the separation systems for ... Mn in 2014 and is projected to expand ... 2023 to reach US$ 19,227.8 Mn in 2023. ...
(Date:4/28/2016)... PUNE, India , April 28, 2016 ... PT, JT, Stirling, and Brayton Cryocoolers), Service (Technical Support, ... Application, and Geography - Global Forecast to 2022", published ... to USD 2.94 Billion by 2022, at a CAGR ... Browse 70 market data Tables and 94 Figures spread ...
(Date:4/28/2016)... ... April 28, 2016 , ... Morris ... open house for regional manufacturers at its Maple Grove, Minnesota technical center, May ... Group, Chiron and Trumpf. Almost 20 leading suppliers of tooling, accessories, software ...
(Date:4/27/2016)... VANCOUVER, British Columbia , April 27, 2016 ... "Gesellschaft" oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... sie im Anschluss an ihre Pressemitteilung vom 13. ... Inc. erhalten hat, ihre Finanzen um zusätzliche 200.000.000 ... auf 4.000.000 Kanadische Dollar zu bringen. Davon wurden ...
Breaking Biology Technology:
(Date:3/9/2016)... , March 9, 2016 This BCC ... future states of the RNA Sequencing (RNA Seq) market ... such as instruments, tools and reagents, data analysis, and ... various segments of the RNA-Sequencing market such as RNA-Sequencing ... Identify the main factors affecting each segment and forecast ...
(Date:3/9/2016)... GARDENS, Fla. , March 9, 2016 /PRNewswire/ ... management authentication and enrollment solutions, today announced the ... DigitalPersona ® Altus multi-factor authentication platform. ... and InfoSec managers to step-up security where it,s ... Washington, DC . ...
(Date:3/3/2016)...  FlexTech, a SEMI Strategic Association Partner, awarded five ... Development, Leadership in Education, and, in a category new ... year of the FLEXI Awards and the winners ... past years . Judging was done on a ... criteria, by a panel of non-affiliated, independent, industry experts. ...
Breaking Biology News(10 mins):